tiprankstipranks
Trending News
More News >
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
Advertisement

Interpace Diagnostics Group (IDXG) Price & Analysis

Compare
413 Followers

IDXG Stock Chart & Stats


Interpace Diagnostics Group News

IDXG FAQ

What was Interpace Diagnostics Group’s price range in the past 12 months?
Interpace Diagnostics Group lowest stock price was $0.44 and its highest was $3.54 in the past 12 months.
    What is Interpace Diagnostics Group’s market cap?
    Interpace Diagnostics Group’s market cap is $3.93M.
      When is Interpace Diagnostics Group’s upcoming earnings report date?
      Interpace Diagnostics Group’s upcoming earnings report date is Nov 05, 2025 which is in 35 days.
        How were Interpace Diagnostics Group’s earnings last quarter?
        Interpace Diagnostics Group released its earnings results on Aug 07, 2025. The company reported -$0.145 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.145.
          Is Interpace Diagnostics Group overvalued?
          According to Wall Street analysts Interpace Diagnostics Group’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Interpace Diagnostics Group pay dividends?
            Interpace Diagnostics Group does not currently pay dividends.
            What is Interpace Diagnostics Group’s EPS estimate?
            Interpace Diagnostics Group’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Interpace Diagnostics Group have?
            Interpace Diagnostics Group has 4,423,093 shares outstanding.
              What happened to Interpace Diagnostics Group’s price movement after its last earnings report?
              Interpace Diagnostics Group reported an EPS of -$0.145 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.19%.
                Which hedge fund is a major shareholder of Interpace Diagnostics Group?
                Currently, no hedge funds are holding shares in IDXG

                Company Description

                Interpace Diagnostics Group

                Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

                Interpace Diagnostics Group (IDXG) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Check-Cap
                ENDRA Life Sciences
                Intelligent Bio Solutions
                Mainz Biomed B.V.
                bioAffinity Technologies, Inc.

                Ownership Overview

                1.06%0.02%98.92%
                0.02% Other Institutional Investors
                98.92% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis